NKGen Biotech, Inc. Common Stock

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024

Contact Information

NKGen Biotech, Inc.
3001 Daimler Street
Santa Ana, CA 92705
United States

NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the body’s immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.

The mission of NKGen Biotech is to improve patients’ lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics.

More information can be found on our website www.nkgenbiotech.com